Cervical Cancer (Diagnostics)

New HPV DNA Testing May Help Identify Those at High Risk

Published in Women's Health Weekly, October 19th, 1998

Human papillomavirus (HPV) has been associated with most cervical dysplasias (pre-cancer) in women, and is an important co-factor in the cause of most cervical cancers. As the severity of dysplasia progresses towards cervical cancer, the prevalence of "high-risk" HPV types also increases.

The question has been raised to whether HPV testing may be used to better triage women with abnormal Papanicoulaou (Pap) tests before colposcopic assessments and biopsies are performed.

A study in the September 1998 issue of Gynecologic Oncology, the journal of the Society of Gynecologic Oncologists (SGO), explored the correlation between HPV test results and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-10-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry